Metropolitan Life Insurance Co. NY raised its stake in MAXIMUS, Inc. (NYSE:MMS) by 75.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 37,223 shares of the health services provider’s stock after buying an additional 16,015 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in MAXIMUS were worth $2,423,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in MMS. Oregon Public Employees Retirement Fund lifted its stake in MAXIMUS by 6,329.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock valued at $25,000 after buying an additional 1,630,329 shares during the period. Epoch Investment Partners Inc. acquired a new position in MAXIMUS in the third quarter valued at about $26,493,000. Credit Suisse AG lifted its stake in MAXIMUS by 73.1% in the third quarter. Credit Suisse AG now owns 703,332 shares of the health services provider’s stock valued at $45,760,000 after buying an additional 297,129 shares during the period. Mackenzie Financial Corp lifted its stake in MAXIMUS by 17.6% in the fourth quarter. Mackenzie Financial Corp now owns 1,853,213 shares of the health services provider’s stock valued at $120,626,000 after buying an additional 277,775 shares during the period. Finally, Renaissance Technologies LLC lifted its stake in MAXIMUS by 117.0% in the third quarter. Renaissance Technologies LLC now owns 403,700 shares of the health services provider’s stock valued at $26,265,000 after buying an additional 217,700 shares during the period. 94.42% of the stock is currently owned by hedge funds and other institutional investors.
NYSE MMS opened at $69.92 on Friday. The stock has a market cap of $4.46 billion, a PE ratio of 21.06, a price-to-earnings-growth ratio of 1.91 and a beta of 0.97. The company has a current ratio of 2.32, a quick ratio of 2.32 and a debt-to-equity ratio of 0.11. MAXIMUS, Inc. has a one year low of $60.00 and a one year high of $73.81.
MAXIMUS (NYSE:MMS) last released its quarterly earnings results on Thursday, February 7th. The health services provider reported $0.86 EPS for the quarter, topping the Zacks’ consensus estimate of $0.80 by $0.06. The company had revenue of $664.60 million for the quarter, compared to analyst estimates of $672.08 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. MAXIMUS’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.89 earnings per share. Research analysts anticipate that MAXIMUS, Inc. will post 3.66 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, February 28th. Stockholders of record on Friday, February 15th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend was Thursday, February 14th. MAXIMUS’s dividend payout ratio is currently 29.41%.
A number of research firms have recently commented on MMS. ValuEngine lowered MAXIMUS from a “buy” rating to a “hold” rating in a research report on Thursday, February 28th. Zacks Investment Research lowered MAXIMUS from a “buy” rating to a “hold” rating in a research report on Tuesday, January 29th.
In other news, Director Russell A. Beliveau sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $64.14, for a total transaction of $64,140.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $70.69, for a total value of $848,280.00. Following the sale, the insider now directly owns 412,874 shares in the company, valued at approximately $29,186,063.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 54,715 shares of company stock worth $3,866,689. 2.20% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION WARNING: “Metropolitan Life Insurance Co. NY Has $2.42 Million Holdings in MAXIMUS, Inc. (MMS)” was first posted by Highlight Press and is owned by of Highlight Press. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://highlightpress.com/2019/03/24/metropolitan-life-insurance-co-ny-has-2-42-million-holdings-in-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Further Reading: Why do companies pay special dividends?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.